Nordic healthcare
Axcel acquires veterinary care provider VetGruppen
Company's co-founder and chief operating officer Rasmus Hansen will remain a significant co-owner alongside the GP
VC-backed Biosergen raises €5m via unit offering ahead of IPO
Company will use the proceeds from the offering to launch clinical trials of its antifungal drug candidate
Summa Equity to sell HyTest in €545m trade deal
Company in 2019 recorded SEK 299m in revenues and an adjusted EBITDA of тЌ15m
Nordic Capital acquires minority stake in Leo Pharma
GP's stake is reportedly smaller than 25%, with the current owner remaining as the majority shareholder
Monterro buys e-health software provider Bliksund
Company is looking to expand in Sweden, Denmark and the UK first, but also further abroad
GP-backed SSI Diagnostica acquires CTK Biotech
Deal comes four years after the GP carved out SSI Diagnostica from the Danish government for DKK 250m
Novo Holdings et al. in $20m round for Reapplix
Company will use the proceeds to commercialise its flagship product across the US
Lifeline in €6.2m round for Tilt Biotherapeutics
Healthcare startup has raised тЌ18m in funding since its foundation in 2013
Main Capital-backed Alfa acquires Joliv
GP plans to merge Joliv and previously acquired e-health business Alfa
DevCo-backed Medix Biochemica adds-on two US companies
Company has so far added on three companies and used its cashflow to acquire them
Carnegie, Handelsbanken lead €45m series-C for Doktor.se
Digital healthcare startup has reportedly raised more than $76m in equity so far
Verdane Capital acquires Finnish company Evondos
Deal is the GP's third investment in a month in the healthcare technology sector
LSP in $50m series-A for Snipr Biome
Lundbeckfonden Emerge invested an undisclosed sum in an exploratory investment in 2017
Karolinska exits Inhalation Sciences
Family-owned investment company RУЅsunda FУЖrvaltning enters the company's capital structure as part of the deal
Almi Invest et al. in SEK 23.8m round for Promimic
Chalmers Ventures and Karolinska Development also participated in the biotech investment
Altor exceeds 25% IRR on Ferrosan Medical Devices exit
Final exit comes five years after GP divested Ferrosan Consumer Health division to Pfizer
EQT in €830m Atos Medical exit to PAI
PAI Partners becomes the third private equity owner of Atos, following EQT and Nordic Capital
IK Investment Partners' Attendo seeks SEK 8bn Stockholm IPO
Care company is expected to list on 30 November